Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 9 | Showing Results 1 - 5 of 42

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

RNS System Post-Approval Study in Epilepsy

The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data...

Ryder Gwinn, M.D.
  • Swedish Medical Center

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy

Key Inclusion Criteria:-Diagnosis of focal epilepsy per 1989 International League Against Epilepsy (ILAE) criteria at least 3 years before study...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

HVP AMPLATZER™ PFO Occluder Post Approval Study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval...

Ethan Korngold MD
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • TOC Gateway - Heart Clinic

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy

Key Inclusion Criteria:-Histologically confirmed diagnosis of supratentorial GBM (Grade 4 astrocytoma)-Radiographic evidence of first recurrence or...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 9 | Showing Results 1 - 5 of 42